LAKE FOREST, Ill., March 27, 2014 /PRNewswire/ -- Hospira (NYSE:
HSP), the world's leading provider of injectable drugs and infusion
technologies, today announced that, for the second consecutive
year, its TheraDoc™ Infection Control Assistant™ software has been
ranked as the top product in the Infection Control & Monitoring
software category in the recently released Best in KLAS Awards
2013: Software and Services Report (more information available at
www.theradoc.com). The full report is available at
www.KLASresearch.com. The rankings are based on data from customer
surveys of North American hospital and clinic executives,
administrators, physicians, nurses, clinicians, and other directors
and managers interacting with healthcare equipment and
infrastructure solutions.
TheraDoc Infection Control Assistant scored the highest overall
performance rating in KLAS' Infection Control & Monitoring
market segment, demonstrating continued excellence and leadership
in serving customers and meeting their
expectations.[1]
"Hospira is proud that direct feedback from users has once again
led to TheraDoc Infection Control Assistant being recognized for
excellence in infection monitoring and surveillance software," said
France Pitera, vice president,
Clinical Information Technology, Hospira. "The TheraDoc team will
continue diligently to ensure that our solutions evolve to meet the
changing clinical and reporting needs of healthcare
organizations."
The TheraDoc Infection Control Assistant helps infection
preventionists improve performance on many of their most
significant challenges, including time spent to deliver accurate
regulatory reporting, time to identification of
healthcare-associated infections (HAIs), time to isolation of
patients with infectious diseases and tracking of organism
resistance.
"TheraDoc Infection Control Assistant pulls patient data
together in a way that enables us to make better clinical decisions
based on our criteria," said Cheryl
Herbert, R.N., C.I.C., executive director of Infection
Prevention at Good Shepherd Medical Center in Longview, Texas. "The system brings in data in
real-time, and displays it in a way that is intuitive. This
complements our EMR by helping us to perform the kind of proactive
surveillance that is so important to helping us get closer to
'zero.'"
The TheraDoc Infection Control Assistant provides infection
preventionists with real-time (a matter of seconds) patient data
needed to make a valid identification of potential infections,
while leaving final determination in the hands of infection
preventionists. TheraDoc Infection Control Assistant also delivers
powerful tools enabling infection preventionists to configure
workflow to their unique needs, develop their own alerts, select
from a large library of existing alerts, and automate creation of
reports for the National Healthcare Safety Network.
As part of a suite of knowledge modules that make critical
patient information and medical knowledge readily available, the
TheraDoc Infection Control Assistant is designed to help clinicians
proactively survey their patient populations, intervene quickly and
appropriately, and improve the quality and safety of patient
care.[2,3] TheraDoc™ Clinical Surveillance System™
software also features Pharmacy Assistant™, a robust clinical
pharmacy surveillance application providing specialized tools for
drug therapy optimization, antimicrobial stewardship management,
adverse drug event monitoring and anticoagulation patient
population management. For more information, visit
www.theradoc.com.
KLAS is a research firm specializing in monitoring and reporting
on the performance of healthcare vendors. KLAS' mission is to
improve delivery by independently measuring vendor performance for
the benefit of its healthcare provider partners, consultants,
investors, and vendors. Working together with executives from more
than 4,500 hospitals and more than 3,000 clinics, KLAS delivers
timely reports, trends, and statistics that provide a solid
overview of vendor performance in the industry. KLAS measures
performance of software, professional services, medical equipment,
and infrastructure vendors.
About Hospira
Hospira, Inc., is the world's leading
provider of injectable drugs and infusion technologies, and a
global leader in biosimilars. Through its broad, integrated
portfolio, Hospira is uniquely positioned to Advance Wellness™ by
improving patient and caregiver safety while reducing healthcare
costs. The company is headquartered in Lake Forest, Ill., and has approximately
17,000 employees. Learn more at www.hospira.com.
1 "Best in KLAS Awards 2013: Software and Services
Report," January 2014. © 2014 KLAS Enterprises, LLC. All
rights reserved. www.KLASresearch.com.
2 Hellinger W, Alvarez S, Brumble L, Keating M, Mendez
J, Darracott R, Young E, Smith R, Mentel J. Optimizing antibiotic
therapy with computerized integration of hospital information
systems and an antibiotic management team (AMT). Poster session
presented at: 42nd Annual Meeting of the Infectious Diseases
Society of America; 2004 Sep 30-Oct
3; Boston, MA.
3 Pass M, Song X, Mackie K, Perl T. Enhanced Isolation
Practices To Improve Patient Safety: Preventing Nosocomial
Transmission in a Hospital. Am J Infect Control. 2006
June;34(5):E105-E106.
SOURCE Hospira, Inc.